Dr. Ahlawalia subspecializes in the treatment of patients with brain tumors and brain metastases.
He serves as the Associate Editor on Tumor Section of Neurosurgery, the official Journal of Congress of Neurological Surgeons (CNS). He is the Associate Editor of ASCO Post, the newsletter of ASCO. He is the Section Editor of NeuroOncology for HemOnc Today. He serves as a reviewer on multiple journals including Cancer, NeuroOncology, Cancer Research, Clinical Cancer Research, BMC Cancer, Molecular Cancer Research.
Dr. Ahluwalia's research focuses on the development of new therapies for patients with brain tumors and brain metastases. He is currently leading several clinical trials involving immune therapies including vaccines, viral-based therapies and immune checkpoint inhibitors as well as targeted therapies. His research results have been presented nationally and internationally and have resulted in over 150 editorials, manuscripts and book chapters.